David Ricks

David Ricks

business United States

David Ricks is the Chief Executive Officer of Eli Lilly and Company, a leading pharmaceutical company known for its innovations in diabetes and weight loss medications, including Zepbound and Mounjaro. Under his leadership, the company announced a significant $27 billion investment to expand its manufacturing capabilities in the United States, aiming to bolster domestic production in response to potential tariffs and supply chain vulnerabilities exposed during the COVID-19 pandemic. Ricks has emphasized the importance of reshoring production and increasing manufacturing capacity to meet the growing demand for Eli Lilly's products.

Global Media Ratings
Dominance
0.01%
Persistence
0 wks
Reach
179,123
Power
6,631$
Sentiment
7.77
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
United Kingdom 2 7.00 0.05% +0% 67,886,011 36,342 $2,700,000 1,445$
Ireland 2 8.00 0.08% +0% 5,030,000 4,207 $5,100 4$
United States 1 9.00 0.02% +0% 331,002,651 74,199 $21,000,000 4,707$
Vietnam 1 4.00 0.06% +0% 97,338,583 56,658 $340,000 198$
Greece 1 8.00 0.04% +0% 10,423,054 4,502 $190,000 82$
Denmark 1 9.00 0.06% +0% 5,792,202 3,214 $350,000 194$
Totals 8 517,472,501 179,122 $24,585,100 6,630$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Ireland Ireland: David Ricks is Eli Lilly’s chief executive who commented on the potential of the new weight-loss pill. 8

The Irish Times – major Irish daily, est. 1859: Lilly’s weight loss pill is a ‘landmark moment’ in the obesity fight – The Irish Times

Ireland Ireland: David Ricks, Eli Lilly’s chief executive, stated that orforglipron may provide a new option for weight management. 8

The Irish Times – major Irish daily, est. 1859: New daily weight-loss pill shows success at clinical trial – The Irish Times

United Kingdom United Kingdom: David Ricks, Eli Lilly’s chief executive, discussed the potential of orforglipron as a new option for weight management. 8

The Guardian: New daily weight-loss pill shows success at clinical trial | Obesity

Denmark Denmark: David Ricks, the CEO of Eli Lilly, stated that orforglipron could provide a new opportunity for people worldwide if approved. 9

Politiken: Novo-rivals vægttabspille består studie som den første af sin slags

Greece Greece: David Ricks, the CEO of Eli Lilly, referred to the new drug as a 'convenient solution, with one pill daily.' 8

Kathimerini: Ερχεται ο αντίπαλος του Ozempic – Νέο χάπι κατά της παχυσαρκίας

United Kingdom United Kingdom: David Ricks, the boss of US pharmaceutical giant Eli Lilly, described the tariffs imposed by Donald Trump as a watershed moment in US economic history. 6

BBC: US pharma boss calls tariffs a ‘pivotal moment'

United States United States: David Ricks is Eli Lilly’s chief executive officer who discussed the company's investment plans. 7

CNN: Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs